(Q35123271)

6 August 2017

1 reference

title

Localized prostate cancer: radiation or surgery? (English)

1 reference

6 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00179-9

31 December 2023

author name string

Eric A. Klein

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735507

31 December 2023

Patrick A. Kupelian

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12735507

31 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12735507

31 December 2023

publication date

1 May 2003

1 reference

full work available at URL

6 August 2017

https://api.elsevier.com/content/article/PII:S0094014302001799?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00179-9

https://api.elsevier.com/content/article/PII:S0094014302001799?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00179-9

Urologic Clinics of North America

31 December 2023

published in

1 reference

6 August 2017

volume

30

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

315-30, ix

1 reference

Radical surgery versus radiotherapy for adenocarcinoma of the prostate

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

More on the uro-oncology research group report of radical surgery vs. radiotherapy for adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

The value of serial prostate specific antigen determinations 5 years after radiotherapy: steeply increasing values characterize 80% of patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Prostate-specific antigen. An important marker for prostate cancer treated by external beam radiation therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Prostate Specific Antigen as an Outcome Variable for T1 and T2 Prostate Cancer Treated by Radiation Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Prostate-specific antigen doubling times are similar in patients with recurrence after radical prostatectomy or radiotherapy: a novel analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Declining rates of extracapsular extension after radical prostatectomy: evidence for continued stage migration

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Interstitial iodine-125 radiation without adjuvant therapy in the treatment of clinically localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer: a 7-year biochemical (PSA) progression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Prostate rebiopsy is a poor surrogate of treatment efficacy in localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Biochemical failure does not predict overall survival after radical prostatectomy for localized prostate cancer: 10-year results

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Benign prostatic glands at surgical margins of radical prostatectomy specimens: frequency and associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Scrutiny of the ASTRO consensus definition of biochemical failure in irradiated prostate cancer patients demonstrates its usefulness and robustness. American Society for Therapeutic Radiology and Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Prostate-specific antigen nadir of 0.5 ng/mL or less defines disease freedom for surgically staged men irradiated for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Posttreatment prostate-specific antigen nadir highly predictive of distant failure and death from prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical prostatectomy and external-beam radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Initial dissection of the lateral fascia reduces the positive margin rate in radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Early hospital discharge after radical retropubic prostatectomy: impact on cost and complication rate

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Radical retropubic prostatectomy outcomes at a community hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Early Continence after Radical Prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Potency, continence and complication rates in 1,870 consecutive radical retropubic prostatectomies

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Tolerance and early outcome results of postprostatectomy three-dimensional conformal radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Late GI and GU complications in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Urinary morbidity following ultrasound-guided transperineal prostate seed implantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Patient-reported symptoms after primary therapy for early prostate cancer: results of a prospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Defining sexual outcomes after treatment for localized prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Salvage radical prostatectomy: outcome measured by serum prostate specific antigen levels

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Predictors for maximal outcome in patients undergoing salvage surgery for radio-recurrent prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Salvage surgery for radiation failure in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Quality of life in patients undergoing salvage procedures for locally recurrent prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Prediction of response to salvage radiation therapy in patients with prostate cancer recurrence after radical prostatectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Second malignancies in prostate carcinoma patients after radiotherapy compared with surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Cost comparison of radical prostatectomy and transperineal brachytherapy for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above

1 reference

https://api.crossref.org/works/10.1016%2FS0094-0143%2802%2900179-9

7 January 2021

Consensus statement: guidelines for PSA following radiation therapy. American Society for Therapeutic Radiology and Oncology Consensus Panel

23

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00179-9

A critical analysis of the interpretation of biochemical failure in surgically treated patients using the American Society for Therapeutic Radiation and Oncology criteria

31 December 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00179-9

Nerve sparing radical prostatectomy for early stage prostate cancer

31 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00179-9

Reducing length of stay after radical prostatectomy

31 December 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00179-9

The feasibility of dose escalation with three-dimensional conformal radiotherapy in patients with prostatic carcinoma

31 December 2023

42

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00179-9

How to explore the patient with a rising PSA after radical prostatectomy: defining local versus systemic failure

31 December 2023

56

1 reference

https://api.crossref.org/works/10.1016/S0094-0143(02)00179-9

31 December 2023

Identifiers

1 reference

release_4msxzbdl5vhnfhs65llqkgn5m4

6 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/4msxzbdl5vhnfhs65llqkgn5m4

24 November 2022

mapped directly with Wikidata item

1 reference